Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

MS&D discloses 5-HT1-like receptor agonists

May 15, 1997

MS&D describes tachykinin antagonists

May 15, 1997

ET antagonists from Warner-Lambert claimed for cerebrovascular disorders

May 15, 1997

CollaGenex promotes Ponstel for short-term dental pain relief

May 14, 1997

New antimigraine agents from Merck Sharp & Dohme

May 14, 1997

Forest submits NDA for antidepressant

May 13, 1997

CRF receptor antagonist from Pfizer active in animal model of depression

May 13, 1997

FDA advisory committee votes against Myotrophin approval

May 13, 1997

Update on HemispheRx Biopharma's Ampligen

May 12, 1997

MS&D reports potent and selective 5-HT1Dalpha agonists

May 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...